Michael F. Berger, PhD
Associate Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Associate Professor
Research Focus
Researcher Michael Berger focuses on massively parallel sequencing of tumor DNA for biomarker discovery and clinical diagnostics.Education
PhD, Harvard UniversityLab Members
Computational Biologist, CMO Technology Innovation
Manager, CMO Technology Innovation
Lab Manager, CMO Technology Innovation
Bioinformatics Engineer, CMO Technology Innovation
Research Assistant, CMO Technology Innovation
Computational Biologist, CMO Technology Innovation
Senior Computational Biologist
Graduate Student
Senior Computational Biologist
Research Assistant
Bioinformatics Technician
Publications
- Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, Hyman DM, Solit DB, Robson ME, Baselga J, Arcila ME, Ladanyi M, Tallman MS, Levine RL, Berger MF. Cell Stem Cell. 2017 Sep 7;21(3):374-382.e4. doi: 10.1016/j.stem.2017.07.010. Epub 2017 Aug 10.
- Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing. Mandelker D, Zhang L, Kemel Y, Stadler ZK, Joseph V, Zehir A, Pradhan N, Arnold A, Walsh MF, Li Y, Balakrishnan AR, Syed A, Prasad M, Nafa K, Carlo MI, Cadoo KA, Sheehan M, Fleischut MH, Salo-Mullen E, Trottier M, Lipkin SM, Lincoln A, Mukherjee S, Ravichandran V, Cambria R, Galle J, Abida W, Arcila ME, Benayed R, Shah R, Yu K, Bajorin DF, Coleman JA, Leach SD, Lowery MA, Garcia-Aguilar J, Kantoff PW, Sawyers CL, Dickler MN, Saltz L, Motzer RJ, O’Reilly EM, Scher HI, Baselga J, Klimstra DS1, Solit DB, Hyman DM, Berger MF, Ladanyi M, Robson ME, Offit K. JAMA. 2017 Sep 5;318(9):825-835. doi: 10.1001/jama.2017.11137.
